These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 4806101)

  • 1. A new anticoagulant extracted from the red cell.
    Cochin A; Dubin A; DeWoskin R; Gilbert HC; Moss GS
    Surg Forum; 1973; 24():70-2. PubMed ID: 4806101
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel inhibitor of factor X activation from the salivary glands of the bed bug Cimex lectularius.
    Valenzuela JG; Guimaraes JA; Ribeiro JM
    Exp Parasitol; 1996 Jul; 83(2):184-90. PubMed ID: 8682187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme.
    Marlar RA; Kleiss AJ; Griffin JH
    Blood; 1982 May; 59(5):1067-72. PubMed ID: 6803853
    [No Abstract]   [Full Text] [Related]  

  • 4. An acquired factor V inhibitor: clinical and laboratory features.
    Shastri KA; Ho C; Logue G
    J Med; 1999; 30(5-6):357-66. PubMed ID: 10851568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and kinetic studies on a circulating anticoagulant in a suspected case of lupus erythematosus.
    Yin ET; Gaston LW
    Thromb Diath Haemorrh; 1965 Sep; 14(1-2):88-115. PubMed ID: 16955969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human protein C: inactivation of factors V and VIII in plasma by the activated molecule.
    Marlar RA; Kleiss AJ; Griffin JH
    Ann N Y Acad Sci; 1981; 370():303-10. PubMed ID: 6791548
    [No Abstract]   [Full Text] [Related]  

  • 7. [A case of sigmoid cancer who acquired factor V inhibitor producibility and treated with factor VIII inhibitor bypassing activity preparation FEIBA--with bibliographic review (author's transl)].
    Abe T; Kazama M; Itokazu K; Kinoshita T; Ogushi T; Tahara C; Fukui H
    Rinsho Ketsueki; 1980 Nov; 21(11):1664-73. PubMed ID: 6782277
    [No Abstract]   [Full Text] [Related]  

  • 8. The inhibitor of prothrombin conversion in plasma of patients on oral anticoagulant treatment.
    Bertina RM; Westhoek-Kuipers ME; Alderkamp GH
    Thromb Haemost; 1981 Jun; 45(3):237-41. PubMed ID: 7281102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation inhibitors.
    Corrigan JJ
    Am J Pediatr Hematol Oncol; 1980; 2(3):281-8. PubMed ID: 6776839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-factor VIII inhibitors and lupus anticoagulants in haemophilia A patients.
    Blanco AN; Cardozo MA; Candela M; Santarelli MT; Pérez Bianco R; Lazzari MA
    Thromb Haemost; 1997 Apr; 77(4):656-9. PubMed ID: 9134638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a modified procedure for Staclot LA for the confirmation of lupus anticoagulants.
    Charles LA; McGlasson DL; Hawksworth BA; Ashcraft JH; Ortel TL
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):601-4. PubMed ID: 7841317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of Echis carinata venom on hemostasis].
    Zimmermann H; Habermann E; Lasch HG
    Thromb Diath Haemorrh; 1971 Jun; 25(3):425-37. PubMed ID: 5561955
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of anticoagulant activity of ethanol extracts from leech in vitro].
    Feng GJ; Zhu ZG; Yu CL; Zhang Q; Chen NN; Lei LS; Wu SG
    Zhong Yao Cai; 2007 Aug; 30(8):909-11. PubMed ID: 18074833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nontoxic mushroom Auricularia auricula contains a polysaccharide with anticoagulant activity mediated by antithrombin.
    Yoon SJ; Yu MA; Pyun YR; Hwang JK; Chu DC; Juneja LR; Mourão PA
    Thromb Res; 2003; 112(3):151-8. PubMed ID: 14967412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rheumatoid arthritis and circulating antifactor VIII anticoagulant of immunoglobulinic nature (IgG)].
    Soria J; Soria C; Girard M; Lejeay A; Kahn MF; Guerin C; de Seze S
    Presse Med (1893); 1971 Feb; 79(7):294. PubMed ID: 5576151
    [No Abstract]   [Full Text] [Related]  

  • 16. A rapid method for isolation and purification of an anticoagulant from Whitmania pigra.
    Zhong S; Cui Z; Sakura N; Wang D; Li J; Zhai Y
    Biomed Chromatogr; 2007 May; 21(5):439-45. PubMed ID: 17370295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved distinction of factor V wild-type and factor V Leiden using a novel prothrombin-based activated protein C resistance assay.
    Wilmer M; Stocker C; Bühler B; Conell B; Calatzis A
    Am J Clin Pathol; 2004 Dec; 122(6):836-42. PubMed ID: 15539375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Circulating anticoagulant in hemophilia A: laboratory evidence of a coagulation factor 8 inhibitor].
    Hule V
    Vnitr Lek; 1967 Sep; 13(9):859-65. PubMed ID: 6081657
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lupus anticoagulant screening: comparison of 5 tests (author's transl)].
    Follea G; Ffrench P; Trzeciak MC; Dechavanne M
    Nouv Rev Fr Hematol (1978); 1981; 23(4):203-7. PubMed ID: 7312614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of prothrombin activation by bothrojaracin, a C-type lectin from Bothrops jararaca venom.
    Monteiro RQ; Zingali RB
    Arch Biochem Biophys; 2000 Oct; 382(1):123-8. PubMed ID: 11051105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.